Cargando…
mRNA COVID-19 Vaccines and Long-Lived Plasma Cells: A Complicated Relationship
mRNA COVID-19 vaccines have hegemonized the world market, and their administration to the population promises to stop the pandemic. However, the waning of the humoral immune response, which does not seem to last so many months after the completion of the vaccination program, has led us to study the...
Autores principales: | Giannotta, Girolamo, Giannotta, Nicola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703557/ https://www.ncbi.nlm.nih.gov/pubmed/34960249 http://dx.doi.org/10.3390/vaccines9121503 |
Ejemplares similares
-
COVID-19 mRNA Vaccines: The Molecular Basis of Some Adverse Events
por: Giannotta, Girolamo, et al.
Publicado: (2023) -
Seroconversion to mRNA SARS-CoV-2 vaccines in patients with autoimmune cytopenias and bone marrow failures
por: Fattizzo, Bruno, et al.
Publicado: (2022) -
Seroconversion to mRNA SARS-CoV-2 Vaccines in Hematologic Patients
por: Fattizzo, Bruno, et al.
Publicado: (2022) -
Autoimmune Complications in Hematologic Neoplasms
por: Barcellini, Wilma, et al.
Publicado: (2021) -
COVID-19 mRNA vaccines
por: Huang, Qingrui, et al.
Publicado: (2021)